{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(5)"],"submitter":["Harris KM"],"pubmed_abstract":["<h4>Importance</h4>Pain related to sickle cell disease (SCD) is complex and associated with social determinants of health. Emotional and stress-related effects of SCD impact daily quality of life and the frequency and severity of pain.<h4>Objective</h4>To explore the association of educational attainment, employment status, and mental health with pain episode frequency and severity among individuals with SCD.<h4>Design, setting, and participants</h4>This is a cross-sectional analysis of patient registry data collected at baseline (2017-2018) from patients treated at 8 sites of the US Sickle Cell Disease Implementation Consortium. Data analysis was performed from September 2020 to March 2022.<h4>Main outcomes and measures</h4>Electronic medical record abstraction and a participant survey pr"],"journal":["JAMA network open"],"pagination":["e2314070"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10196879"],"repository":["biostudies-literature"],"pubmed_title":["Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease."],"pmcid":["PMC10196879"],"pubmed_authors":["Hussain FA","Calhoun CL","Melvin CL","Gibson R","Harris KM","Bauer A","Preiss L","Hankins JS","Masese R","Sickle Cell Disease Implementation Consortium","Glassberg J","King AA","Varughese T","Treadwell M"],"additional_accession":[]},"is_claimable":false,"name":"Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease.","description":"<h4>Importance</h4>Pain related to sickle cell disease (SCD) is complex and associated with social determinants of health. Emotional and stress-related effects of SCD impact daily quality of life and the frequency and severity of pain.<h4>Objective</h4>To explore the association of educational attainment, employment status, and mental health with pain episode frequency and severity among individuals with SCD.<h4>Design, setting, and participants</h4>This is a cross-sectional analysis of patient registry data collected at baseline (2017-2018) from patients treated at 8 sites of the US Sickle Cell Disease Implementation Consortium. Data analysis was performed from September 2020 to March 2022.<h4>Main outcomes and measures</h4>Electronic medical record abstraction and a participant survey pr","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-25T22:36:20.929Z","creation":"2025-04-06T09:05:00.644Z"},"accession":"S-EPMC10196879","cross_references":{"pubmed":["37200033"],"doi":["10.1001/jamanetworkopen.2023.14070"]}}